Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Papadopoulos

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
CNS Drugs|August 3, 2018
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm AnalysisDimitrios Papadopoulos, Dimos-Dimitrios D Mitsikostas
CNS Drugs|February 27, 2019
Authors' Reply to Tsivgoulis et al.: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis"Dimitrios Papadopoulos, Dimos-Dimitrios D Mitsikostas
Waste Management (New York, N.Y.)|March 27, 2012
Hazardous medical waste generation rates of different categories of health-care facilitiesDimitrios Komilis, Anastassia Fouki, Dimitrios Papadopoulos
Pain Physician|March 21, 2013
Bilateral thoracic splanchnic nerve radiofrequency thermocoagulation for the management of end-stage pancreatic abdominal cancer painDimitrios Papadopoulos, Georgia Kostopanagiotou, Chrysanthi Batistaki
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 14, 2022
Socioeconomic status and sleep health: a narrative synthesis of 3 decades of empirical researchDimitrios Papadopoulos, Faustin Armel Etindele Sosso
Headache|July 24, 2010
Sleep and headache: the clinical relationshipDimos D Mitsikostas, Alexandros Viskos, Dimitrios Papadopoulos
Multiple Sclerosis and Related Disorders|September 17, 2019
Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatmentsPanagiotis Gklinos, Dimitrios Papadopoulos, Dimos D Mitsikostas
The Journal of Steroid Biochemistry and Molecular Biology|October 12, 2017
Physiological implications of DHEAS-induced non-classical steroid hormone signalingDimitrios Papadopoulos, Mazen Shihan, Georgios Scheiner-Bobis
Experimental Neurology|December 13, 2005
Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the ratDimitrios Papadopoulos, Danielle Pham-Dinh, Richard Reynolds
Plos One|October 5, 2023
Syntactic and affective prosody recognition: Schizophrenia vs. Autism spectrum disordersMaria Martzoukou, Dimitrios Papadopoulos, Mary H Kosmidis
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
CNS Drugs|August 3, 2018
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm AnalysisDimitrios Papadopoulos, Dimos-Dimitrios D Mitsikostas
CNS Drugs|February 27, 2019
Authors' Reply to Tsivgoulis et al.: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis"Dimitrios Papadopoulos, Dimos-Dimitrios D Mitsikostas
Waste Management (New York, N.Y.)|March 27, 2012
Hazardous medical waste generation rates of different categories of health-care facilitiesDimitrios Komilis, Anastassia Fouki, Dimitrios Papadopoulos
Pain Physician|March 21, 2013
Bilateral thoracic splanchnic nerve radiofrequency thermocoagulation for the management of end-stage pancreatic abdominal cancer painDimitrios Papadopoulos, Georgia Kostopanagiotou, Chrysanthi Batistaki
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 14, 2022
Socioeconomic status and sleep health: a narrative synthesis of 3 decades of empirical researchDimitrios Papadopoulos, Faustin Armel Etindele Sosso
Headache|July 24, 2010
Sleep and headache: the clinical relationshipDimos D Mitsikostas, Alexandros Viskos, Dimitrios Papadopoulos
Multiple Sclerosis and Related Disorders|September 17, 2019
Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatmentsPanagiotis Gklinos, Dimitrios Papadopoulos, Dimos D Mitsikostas
The Journal of Steroid Biochemistry and Molecular Biology|October 12, 2017
Physiological implications of DHEAS-induced non-classical steroid hormone signalingDimitrios Papadopoulos, Mazen Shihan, Georgios Scheiner-Bobis
Experimental Neurology|December 13, 2005
Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the ratDimitrios Papadopoulos, Danielle Pham-Dinh, Richard Reynolds
Plos One|October 5, 2023
Syntactic and affective prosody recognition: Schizophrenia vs. Autism spectrum disordersMaria Martzoukou, Dimitrios Papadopoulos, Mary H Kosmidis
Pageof 19